Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Galapagos
Galapagos
Galapagos halts lupus CAR-T program, confirms 100 layoffs so far this year
Fierce Biotech
Fri, 02/23/24 - 10:32 am
Galapagos
layoffs
lupus
CAR-T
Frontier gets $80M, Galapagos’ backing to make a better KRAS drug
BioPharma Dive
Thu, 02/22/24 - 11:18 pm
Frontier Medicines
Galapagos
funding
KRAS inhibitors
Galapagos wants to find new small molecule species for cancer with BridGene
Fierce Biotech
Wed, 01/3/24 - 05:05 pm
BridGene Biosciences
Galapagos
cancer
small molecule drugs
Alfasigma to acquire Galapagos’ Jyseleca business
Pharmaceutical Business Review
Tue, 01/2/24 - 09:58 am
Galapagos
Alfasigma
Jyseleca
filgotinib
ulcerative colitis
rheumatoid arthritis
Galapagos plans to cut 100 jobs after striking deal to transfer Jyseleca, 400 staffers to Alfasigma
Fierce Pharma
Tue, 10/31/23 - 11:28 am
Galapagos
Jyseleca
Alfasigma
layoffs
Galapagos, following Sanofi’s playbook, offloads French R&D site to drug discovery CRO
Fierce Biotech
Fri, 03/31/23 - 10:27 am
Galapagos
Sanofi
R&D
CROs
NovAliX
Galapagos' Jyseleca flops phase 3 Crohn's study, dealing another blow to troubled JAK inhibitor
Fierce Pharma
Fri, 02/10/23 - 11:09 am
Galapagos
FDA
filgotinib
Crohn's Disease
clinical trials
Jyseleca
Galapagos lays off 200 staff, drops kidney and fibrosis programs in renewed CAR-T push
Fierce Biotech
Fri, 11/4/22 - 11:01 am
Galapagos
layoffs
CAR-T
Plaque psoriasis and psoriatic arthritis: trials to watch in 2022
Clinical Trials Arena
Tue, 08/9/22 - 06:32 am
clinical trials
psoriasis
psoriatic arthritis
Lipidor
AKP-02
Amgen
ABP-654
Hengyi
HPP-737
Galapagos
Jyseleca
Galapagos cleans closet of another 4 programs to make room for CAR-T ambitions
Fierce Biotech
Sun, 08/7/22 - 11:22 pm
Galapagos
CAR-T
In first M&A strike, Paul Stoffels lays out 5-year plan to turn Galapagos around
Fierce Biotech
Thu, 06/23/22 - 10:54 am
Galapagos
Pharma CEOs
Paul Stoffels
M&A
CAR-T
AboundBio
CellPoint
Galapagos to enter cell therapy space with acquisition of CellPoint and AboundBio
Seeking Alpha
Tue, 06/21/22 - 11:50 pm
Galapagos
cell therapy
CellPoint
AboundBio
CAR-T
Galapagos’ Jyseleca gets UK marketing authorization for ulcerative colitis
Pharmaceutical Business Review
Wed, 01/19/22 - 10:57 am
Galapagos
UK
ulcerative colitiis
Jyseleca
filgotinib
Galapagos CEO to retire, though successor yet to be announced
BioPharma Dive
Tue, 08/31/21 - 10:03 pm
Galapagos
Pharma CEOs
Galapagos avoids 'complete whiff' as key anti-inflammatory drug fails to beat placebo in midphase trials
Fierce Biotech
Thu, 07/15/21 - 12:25 pm
Galapagos
clinical trials
rheumatoid arthritis
ulcerative colitis
psoriasis
filgotinib
Galapagos Touts Positive Post-Hoc Data, but Likely Won’t Gun for US Approval
BioSpace
Mon, 07/12/21 - 11:35 pm
Galapagos
ulcerative colitis
filgotinib
Galapagos reports long-awaited safety data for inflammation drug
BioPharma Dive
Thu, 03/4/21 - 11:26 pm
Galapagos
inflammation
clinical trials
filgotinib
Gilead's $5B Galapagos black hole widens as pair toss out phase 3 asset after flop
Fierce Biotech
Wed, 02/10/21 - 10:29 am
Gilead Sciences
Galapagos
IPF
ziritaxestat
Gilead downsizes multibillion-dollar deal once at center of CEO's rebuild
Bizjournals
Tue, 12/15/20 - 08:31 pm
Gilead Sciences
Galapagos
clinical trials
filgotinib
rheumatoid arthritis
inflammatory bowel disease
Galapagos “win” highlights crowded idiopathic pulmonary fibrosis pipeline
EP Vantage
Fri, 12/4/20 - 10:48 am
Galapagos
GLPG1205
idiopathic pulmonary fibrosis
clinical trials
Pages
1
2
3
4
5
6
next ›
last »